COMMUNICATION
|
doi:10.20944/preprints202410.1881.v1
Subject:
Medicine And Pharmacology,
Oncology And Oncogenics
Keywords:
metastatic melanoma; clinical trial; peptide vaccine; cancer; adverse events; Treatment-related adverse events; biologic sex
Online: 24 October 2024 (10:10:46 CEST)